{"type": "rich", "version": "1.0", "title": "DELII Trial: Ultra-Low-Dose Nivolumab in Relapsed Refractory Solid Tumors", "author_name": "", "author_url": "https://buttondown.com/krishnakumar", "provider_name": "Buttondown", "provider_url": "https://buttondown.com", "html": "<iframe scrolling=\"no\" style=\"width:100%!important;height:300px;position:relative;\" src=\"https://buttondown.com/krishnakumar?as_embed=true\"></iframe>", "width": 600, "height": 300}